IT-SECONDs: ITalian Validation of the Simplified Evaluation of CONsciousness Disorders Scale

Sponsor
Fondazione Don Carlo Gnocchi Onlus (Other)
Overall Status
Recruiting
CT.gov ID
NCT05714215
Collaborator
Carlo Besta Neurological Institute (Other)
60
1
24.1
2.5

Study Details

Study Description

Brief Summary

The Coma Recovery Scale-Revised (CRS-R) is the recommended diagnostic scale for Consciousness but it requires time, training, and provides total scores that do not always reflect the correct level of consciousness Recently, a new short-term assessment tool for consciousness assessment has been validated, which could easily be implemented in daily practice to determine the level of consciousness in severely brain injured individuals: the Simplified Evaluation of CONsciousness Disorders (SECONDs) .Its administration should be significantly shorter than CRS-R and accurate to allow monitoring of consciousness in the subacute / chronic phase. The SECONDs scale was constructed by selecting the items that, based on the latest scientific evidence, are most frequently associated with a Minimally Consciousness State. In fact, recent studies have shown that 5 items of the CRS-R allow to identify 99% of individuals with Minimally Consciousness State 1) reproducible movement on command, 2) visual pursuit 3) visual fixation 4) automatic motor response, and 5) localization to pain) 12. In addition, some changes have been introduced such as 1) the assessment of fixation and visual tracking through the use of the mirror 2) the use of autobiographical questions for the assessment of communication 3) the reduction of the number of orders on command to 2 of 3 instead of 3 out of 4 as in the CRS-R. All these changes have been made to minimize time for administration without compromising the accuracy of consciousness detection, to improve feasibility in clinical practice, and also to limit fatigue, which could produce better patient concentration and collaboration.

The aim of the multicentre study is to carry out a cross-cultural translation of the SECONDs assessment scale into Italian and to perform a validation between operators of different professions of the Italian version. validation will be conducted on a group of patients with prolunged Disorders of Consciousness in the subacute phase admitted to two Units of Severe Acquired Brain Injuries of the Don Carlo Gnocchi Foundation of Florence and Sant'Angelo dei Lombardi, and in the chronic phase IRCCS Foundation Carlo Besta Neurological Institute

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The first phase involves the Italian translation of the SECONDs scale through a rigorous multi-stage review and the drafting of the working and final versions. First, the original scale will undergo a forward translation into Italian by a certified translator. The Italian version obtained will then be discussed by the team of experts from the 3 centers participating in the study for transcultural adaptation. Then the revised Italian version will be subsequently back translated into the original language by another certified translator blinded from the original version. Any discrepancy will be thoroughly discussed between the interdisciplinary Italian group and with the external expert from the group that originally developed the scale, and the Italian version shall be re-defined, with the aim of determining the conceptual, semantic, and operational equivalence of the translated scale. (Phase 1) The second phase involves a pilot study in which the final Italian version of the identified scale will be administered to a small group of patients to determine its intra and interoperative validity (Phase 2A) Subsequently, the multicentre validation of the Italian scale is envisaged on a larger group of patients, 38 admitted to inpatient intensive rehabilitation in the subacute phase (Don Gnocchi Foundation) and 22 admitted to outpatient rehabilitation in the chronic phase (Istituto Besta) (Phase 2B).

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    ITalian Translation and Transcultural Validation of the Simplified Evaluation of CONsciousness Disorders (SECONDs) Scale: a Multicentre Study
    Actual Study Start Date :
    Oct 28, 2021
    Actual Primary Completion Date :
    Jun 15, 2022
    Anticipated Study Completion Date :
    Oct 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. The concurrent validity of the transcultural adaptation of the SECONDs scale with the CRS-R (correlation coefficient for Spearman's ranks) [21 months]

      The endpoint of the study is the creation of a valid and reliable transcultural adaptation of the SECONDs scale

    2. the indexes of agreement between inter and intra examiners (index K) [21 months]

      The endpoint of the study is the creation of a valid and reliable transcultural adaptation of the SECONDs scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of Severe Acquired Brain Injury sABI and Disorder of Consciousness

    •> 28 days from the acute event

    • age> 18 years

    • No history of neurological or psychiatric deficits

    • Mother tongue: Italian

    • Clinical stability (eg, absence of mechanical ventilation, sedation, infection, ensuing seizures).

    • Signature of the informed consent by the legal representative

    Exclusion Criteria:
    • Appearance of a second brain event

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IRCCS-don Gnocchi Foundation Florence Italy 50143

    Sponsors and Collaborators

    • Fondazione Don Carlo Gnocchi Onlus
    • Carlo Besta Neurological Institute

    Investigators

    • Principal Investigator: Bahia Hakiki, Dr, IRCCS-Fondazione Don Gnocchi-Florence
    • Study Director: Bahia Hakiki, Dr, IRCCS-Fondazione Don Gnocchi-Florence

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Fondazione Don Carlo Gnocchi Onlus
    ClinicalTrials.gov Identifier:
    NCT05714215
    Other Study ID Numbers:
    • IT-SECONDs
    First Posted:
    Feb 6, 2023
    Last Update Posted:
    Feb 6, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fondazione Don Carlo Gnocchi Onlus
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 6, 2023